Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for SP3
Z-value: 3.12
Motif logo
Transcription factors associated with SP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP3 | hg19_v2_chr2_-_174830430_174830563 | 0.18 | 3.3e-01 | Click! |
Activity profile of SP3 motif
Sorted Z-values of SP3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_+_2466218 | 8.66 |
ENST00000155840.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chr12_+_6419877 | 6.66 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
| chr22_-_50746027 | 6.65 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
| chr18_+_11981427 | 6.53 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr16_+_1203194 | 6.36 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr22_-_50746001 | 6.03 |
ENST00000359337.4
|
PLXNB2
|
plexin B2 |
| chr18_+_11981547 | 6.02 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr14_+_104552016 | 5.54 |
ENST00000551177.1
ENST00000546892.2 ENST00000455920.2 |
ASPG
|
asparaginase homolog (S. cerevisiae) |
| chr18_+_11981014 | 5.53 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr21_+_35445827 | 5.44 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
| chr21_-_42879909 | 5.37 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr16_-_66952779 | 5.37 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
| chr17_+_81037473 | 5.31 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
| chr14_-_21566731 | 5.20 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr7_-_149470297 | 4.92 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr22_-_43583079 | 4.62 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr9_-_97401782 | 4.61 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr21_-_42880075 | 4.58 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr20_-_52210368 | 4.52 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
| chr1_+_955448 | 4.52 |
ENST00000379370.2
|
AGRN
|
agrin |
| chr7_+_5322561 | 4.49 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr11_+_45944190 | 4.47 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr18_+_29078131 | 4.46 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr9_-_139581848 | 4.46 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr12_+_52626898 | 4.46 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr11_+_289155 | 4.45 |
ENST00000409655.1
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr16_+_67465016 | 4.45 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr19_-_39226045 | 4.38 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
| chr1_+_16375284 | 4.36 |
ENST00000375667.3
|
CLCNKB
|
chloride channel, voltage-sensitive Kb |
| chr16_+_29817399 | 4.36 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr1_+_33207381 | 4.33 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
| chr15_-_90358048 | 4.31 |
ENST00000300060.6
ENST00000560137.1 |
ANPEP
|
alanyl (membrane) aminopeptidase |
| chr4_-_1166623 | 4.30 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
| chr21_+_46825032 | 4.27 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr3_+_154797428 | 4.24 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
| chr21_+_42688686 | 4.17 |
ENST00000398652.3
ENST00000398647.3 |
FAM3B
|
family with sequence similarity 3, member B |
| chr9_-_130331297 | 4.17 |
ENST00000373312.3
|
FAM129B
|
family with sequence similarity 129, member B |
| chr16_-_66952742 | 4.16 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
| chr16_+_77246337 | 4.12 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
| chr17_+_79761997 | 4.11 |
ENST00000400723.3
ENST00000570996.1 |
GCGR
|
glucagon receptor |
| chr17_+_7788104 | 4.08 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
| chr2_+_47596287 | 4.06 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr18_+_29077990 | 4.05 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr3_+_37903432 | 3.98 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr11_+_706113 | 3.96 |
ENST00000318562.8
ENST00000533256.1 ENST00000534755.1 |
EPS8L2
|
EPS8-like 2 |
| chr15_+_41136216 | 3.95 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_-_7164410 | 3.89 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr9_+_116638630 | 3.85 |
ENST00000452710.1
ENST00000374124.4 |
ZNF618
|
zinc finger protein 618 |
| chr15_+_80445232 | 3.85 |
ENST00000561421.1
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr4_-_1166954 | 3.84 |
ENST00000514490.1
ENST00000431380.1 ENST00000503765.1 |
SPON2
|
spondin 2, extracellular matrix protein |
| chr19_-_11529225 | 3.83 |
ENST00000567431.1
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
| chr15_+_41136586 | 3.83 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr9_-_139581875 | 3.81 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr2_+_10091815 | 3.80 |
ENST00000324907.9
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr5_+_78407602 | 3.79 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
| chr2_+_10091783 | 3.78 |
ENST00000324883.5
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr15_-_54051831 | 3.76 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
| chr21_+_44394742 | 3.76 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
| chr11_+_289110 | 3.76 |
ENST00000409548.2
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr2_+_120189422 | 3.75 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr2_+_238600788 | 3.72 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr20_-_22565101 | 3.70 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
| chr15_+_41136369 | 3.67 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr11_-_6677018 | 3.65 |
ENST00000299441.3
|
DCHS1
|
dachsous cadherin-related 1 |
| chr3_-_185542761 | 3.65 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr8_-_144815966 | 3.58 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr12_-_6483969 | 3.57 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr11_+_2923423 | 3.51 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chrX_+_109245863 | 3.51 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr12_-_54982300 | 3.50 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr3_-_185542817 | 3.49 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr2_+_105471969 | 3.47 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr15_+_80445113 | 3.46 |
ENST00000407106.1
ENST00000261755.5 |
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr13_-_114018400 | 3.45 |
ENST00000375430.4
ENST00000375431.4 |
GRTP1
|
growth hormone regulated TBC protein 1 |
| chr15_-_65067773 | 3.45 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr11_+_130029457 | 3.45 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
| chr5_-_2751762 | 3.44 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
| chr20_-_52790055 | 3.42 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr10_-_126849068 | 3.42 |
ENST00000494626.2
ENST00000337195.5 |
CTBP2
|
C-terminal binding protein 2 |
| chr1_-_22263790 | 3.39 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr11_-_70963538 | 3.39 |
ENST00000413503.1
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr20_+_62371206 | 3.35 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
| chrX_-_3631635 | 3.34 |
ENST00000262848.5
|
PRKX
|
protein kinase, X-linked |
| chr12_-_6484376 | 3.33 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr7_-_148725733 | 3.32 |
ENST00000286091.4
|
PDIA4
|
protein disulfide isomerase family A, member 4 |
| chr16_+_56691911 | 3.31 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
| chr6_+_132129151 | 3.30 |
ENST00000360971.2
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| chr19_+_17905919 | 3.28 |
ENST00000318683.6
ENST00000600777.1 ENST00000595387.1 |
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
| chr6_+_54711533 | 3.28 |
ENST00000306858.7
|
FAM83B
|
family with sequence similarity 83, member B |
| chrX_-_2847366 | 3.27 |
ENST00000381154.1
|
ARSD
|
arylsulfatase D |
| chr16_+_55357672 | 3.27 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
| chr3_-_194207388 | 3.26 |
ENST00000457986.1
|
ATP13A3
|
ATPase type 13A3 |
| chr2_+_27665232 | 3.24 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
| chr11_-_93276514 | 3.20 |
ENST00000526869.1
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr19_-_2015699 | 3.20 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
| chr11_-_441964 | 3.19 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
| chr1_-_2126192 | 3.18 |
ENST00000378546.4
|
C1orf86
|
chromosome 1 open reading frame 86 |
| chr21_-_40720995 | 3.17 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr1_-_150946911 | 3.17 |
ENST00000457392.1
ENST00000421609.1 |
CERS2
|
ceramide synthase 2 |
| chr9_+_116638562 | 3.16 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr19_+_18284477 | 3.16 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr20_-_62462566 | 3.13 |
ENST00000245663.4
ENST00000302995.2 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
| chr3_+_12329397 | 3.10 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr17_-_7165662 | 3.08 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr2_-_10220538 | 3.07 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
| chr22_-_37915247 | 3.05 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr1_-_150947299 | 3.04 |
ENST00000361419.5
|
CERS2
|
ceramide synthase 2 |
| chr7_+_73242490 | 3.04 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
| chr10_+_82214010 | 3.04 |
ENST00000481124.1
|
TSPAN14
|
tetraspanin 14 |
| chr2_+_11295498 | 3.02 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
| chr3_-_46735132 | 3.02 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
| chr3_+_53195517 | 3.00 |
ENST00000487897.1
|
PRKCD
|
protein kinase C, delta |
| chr14_+_24563262 | 3.00 |
ENST00000559250.1
ENST00000216780.4 ENST00000560736.1 ENST00000396973.4 ENST00000559837.1 |
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
| chr19_-_51327034 | 3.00 |
ENST00000301420.2
ENST00000448701.2 |
KLK1
|
kallikrein 1 |
| chr17_-_7167279 | 2.99 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
| chr8_+_95653373 | 2.99 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr2_+_10183651 | 2.99 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr22_+_45064593 | 2.98 |
ENST00000432186.1
|
PRR5
|
proline rich 5 (renal) |
| chr19_-_51412584 | 2.98 |
ENST00000431178.2
|
KLK4
|
kallikrein-related peptidase 4 |
| chr2_+_11295624 | 2.98 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr21_-_44846999 | 2.97 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr11_+_2923619 | 2.97 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_+_55587266 | 2.96 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr3_+_154797636 | 2.96 |
ENST00000481828.1
|
MME
|
membrane metallo-endopeptidase |
| chr5_+_2752334 | 2.95 |
ENST00000505778.1
ENST00000515640.1 ENST00000397835.4 |
C5orf38
|
chromosome 5 open reading frame 38 |
| chr15_+_41136263 | 2.95 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_-_7166500 | 2.95 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
| chr3_-_53290016 | 2.94 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
| chr19_-_33555780 | 2.92 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
| chr7_-_73184588 | 2.91 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr7_-_149470540 | 2.91 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr8_+_19171487 | 2.91 |
ENST00000519207.1
|
SH2D4A
|
SH2 domain containing 4A |
| chr3_-_128840604 | 2.90 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
| chr17_+_42081914 | 2.89 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr15_+_41136734 | 2.89 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr7_-_148725544 | 2.88 |
ENST00000413966.1
|
PDIA4
|
protein disulfide isomerase family A, member 4 |
| chr19_+_54371114 | 2.88 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr3_+_154797877 | 2.87 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
| chr3_-_27525826 | 2.87 |
ENST00000454389.1
ENST00000440156.1 ENST00000437179.1 ENST00000446700.1 ENST00000455077.1 ENST00000435667.2 ENST00000388777.4 ENST00000425128.2 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr11_+_46403303 | 2.87 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr22_-_37415475 | 2.86 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
| chr2_+_27665289 | 2.86 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
| chr3_-_46735155 | 2.85 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
| chr2_-_20424844 | 2.84 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chrX_+_9433289 | 2.83 |
ENST00000422314.1
|
TBL1X
|
transducin (beta)-like 1X-linked |
| chr8_+_95653302 | 2.83 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chrX_+_117629766 | 2.82 |
ENST00000276204.6
ENST00000276202.7 |
DOCK11
|
dedicator of cytokinesis 11 |
| chr7_+_150497569 | 2.82 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr16_-_31147020 | 2.82 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chr16_-_54320675 | 2.81 |
ENST00000329734.3
|
IRX3
|
iroquois homeobox 3 |
| chr11_+_2482661 | 2.81 |
ENST00000335475.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chr21_-_40720974 | 2.80 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr12_-_53297432 | 2.80 |
ENST00000546900.1
|
KRT8
|
keratin 8 |
| chr5_-_180237445 | 2.80 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr17_+_48712206 | 2.79 |
ENST00000427699.1
ENST00000285238.8 |
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
| chr14_-_38064198 | 2.78 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr10_-_135171178 | 2.78 |
ENST00000368551.1
|
FUOM
|
fucose mutarotase |
| chr12_-_106641728 | 2.77 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
| chr11_+_706595 | 2.77 |
ENST00000531348.1
ENST00000530636.1 |
EPS8L2
|
EPS8-like 2 |
| chr10_+_11784360 | 2.77 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr21_+_44394620 | 2.77 |
ENST00000291547.5
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
| chr2_-_113993020 | 2.75 |
ENST00000465084.1
|
PAX8
|
paired box 8 |
| chr21_+_44073860 | 2.75 |
ENST00000335512.4
ENST00000539837.1 ENST00000291539.6 ENST00000380328.2 ENST00000398232.3 ENST00000398234.3 ENST00000398236.3 ENST00000328862.6 ENST00000335440.6 ENST00000398225.3 ENST00000398229.3 ENST00000398227.3 |
PDE9A
|
phosphodiesterase 9A |
| chr16_+_23194033 | 2.75 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
| chr19_+_45281118 | 2.75 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr2_+_47596634 | 2.75 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
| chr11_-_93276582 | 2.75 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr6_+_168227611 | 2.74 |
ENST00000344191.4
ENST00000351017.4 ENST00000392108.3 ENST00000366806.2 ENST00000392112.1 ENST00000400824.4 ENST00000447894.2 ENST00000400822.3 |
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
| chr6_+_1312675 | 2.73 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chr9_+_137218362 | 2.72 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr11_+_134201911 | 2.71 |
ENST00000389881.3
|
GLB1L2
|
galactosidase, beta 1-like 2 |
| chr10_+_135122906 | 2.71 |
ENST00000368554.4
|
ZNF511
|
zinc finger protein 511 |
| chr6_+_12012170 | 2.71 |
ENST00000487103.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
| chr3_-_176915215 | 2.71 |
ENST00000457928.2
ENST00000422442.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr19_-_11530012 | 2.71 |
ENST00000380456.3
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
| chr21_+_42688657 | 2.70 |
ENST00000357985.2
|
FAM3B
|
family with sequence similarity 3, member B |
| chr9_-_33167308 | 2.69 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| chr2_-_197036289 | 2.68 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
| chr1_-_71513471 | 2.68 |
ENST00000370931.3
ENST00000356595.4 ENST00000306666.5 ENST00000370932.2 ENST00000351052.5 ENST00000414819.1 ENST00000370924.4 |
PTGER3
|
prostaglandin E receptor 3 (subtype EP3) |
| chr16_-_2908155 | 2.67 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr17_-_1389419 | 2.67 |
ENST00000575158.1
|
MYO1C
|
myosin IC |
| chr1_+_209848749 | 2.67 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
| chr11_+_134201768 | 2.67 |
ENST00000535456.2
ENST00000339772.7 |
GLB1L2
|
galactosidase, beta 1-like 2 |
| chr1_+_9294822 | 2.67 |
ENST00000377403.2
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
| chr9_+_140317802 | 2.67 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr2_+_238600933 | 2.67 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr4_-_1107306 | 2.66 |
ENST00000433731.2
ENST00000333673.5 ENST00000382968.5 |
RNF212
|
ring finger protein 212 |
| chr2_+_219264762 | 2.65 |
ENST00000452977.1
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr11_+_64073022 | 2.65 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr8_-_11725549 | 2.64 |
ENST00000505496.2
ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB
|
cathepsin B |
| chr19_+_50015870 | 2.64 |
ENST00000599701.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr2_-_20425158 | 2.64 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr1_+_31886653 | 2.63 |
ENST00000536384.1
|
SERINC2
|
serine incorporator 2 |
| chr12_-_54982420 | 2.62 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr19_+_55591743 | 2.62 |
ENST00000588359.1
ENST00000245618.5 |
EPS8L1
|
EPS8-like 1 |
| chr11_+_64949158 | 2.62 |
ENST00000527739.1
ENST00000526966.1 ENST00000533129.1 ENST00000524773.1 |
CAPN1
|
calpain 1, (mu/I) large subunit |
| chr1_-_16532985 | 2.61 |
ENST00000441785.1
ENST00000449495.1 |
ARHGEF19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
| chr5_+_2752258 | 2.61 |
ENST00000334000.3
|
C5orf38
|
chromosome 5 open reading frame 38 |
| chr11_+_65082289 | 2.61 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
| chr17_-_1389228 | 2.60 |
ENST00000438665.2
|
MYO1C
|
myosin IC |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 8.7 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 2.2 | 2.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 2.1 | 18.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 2.1 | 6.2 | GO:0003192 | mitral valve formation(GO:0003192) |
| 2.0 | 11.8 | GO:0030421 | defecation(GO:0030421) |
| 2.0 | 7.9 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 2.0 | 7.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 2.0 | 5.9 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 1.9 | 5.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 1.8 | 1.8 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 1.8 | 5.3 | GO:0048627 | myoblast development(GO:0048627) |
| 1.7 | 5.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.7 | 6.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.7 | 5.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.7 | 8.5 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.7 | 6.7 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.7 | 14.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 1.6 | 4.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.6 | 6.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.6 | 9.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 1.6 | 6.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.6 | 4.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.5 | 7.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.5 | 7.7 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.5 | 6.1 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.5 | 6.0 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 | 7.5 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.4 | 4.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.4 | 1.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 1.4 | 4.2 | GO:1903570 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.4 | 5.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 1.4 | 8.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.4 | 5.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 1.4 | 5.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.3 | 1.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 1.3 | 3.9 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.3 | 6.5 | GO:0015862 | uridine transport(GO:0015862) |
| 1.3 | 9.0 | GO:0097473 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.3 | 1.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 1.3 | 3.8 | GO:1990575 | mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 1.3 | 8.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.3 | 3.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.2 | 3.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 | 3.7 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 1.2 | 3.7 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 1.2 | 3.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.2 | 6.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.2 | 15.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 1.2 | 1.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 1.2 | 1.2 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
| 1.2 | 3.5 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.2 | 4.7 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.2 | 5.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 1.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
| 1.1 | 3.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.1 | 10.2 | GO:0046618 | drug export(GO:0046618) |
| 1.1 | 9.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 | 29.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.1 | 16.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 | 18.9 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.1 | 5.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.1 | 3.3 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.1 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.1 | 7.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.1 | 4.3 | GO:0051413 | response to cortisone(GO:0051413) |
| 1.1 | 3.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 1.1 | 8.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.1 | 4.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.1 | 7.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.1 | 2.1 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 1.1 | 4.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.1 | 4.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.0 | 5.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.0 | 9.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 1.0 | 2.1 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 1.0 | 2.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 1.0 | 4.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 | 10.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.0 | 13.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.0 | 9.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.0 | 3.0 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.0 | 2.0 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 1.0 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.0 | 3.0 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.0 | 3.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.0 | 3.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.0 | 2.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 1.0 | 1.9 | GO:1901656 | glycoside transport(GO:1901656) |
| 1.0 | 15.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.0 | 5.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.0 | 3.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 | 2.9 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 1.0 | 4.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.0 | 6.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.9 | 1.9 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 0.9 | 2.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.9 | 4.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.9 | 2.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.9 | 3.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 | 0.9 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.9 | 5.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.9 | 0.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.9 | 0.9 | GO:0009798 | axis specification(GO:0009798) |
| 0.9 | 2.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.9 | 2.8 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.9 | 14.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.9 | 0.9 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.9 | 5.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.9 | 2.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.9 | 4.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.9 | 1.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.9 | 1.9 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.9 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.9 | 2.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.9 | 6.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.9 | 2.7 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.9 | 2.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.9 | 3.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.9 | 2.7 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.9 | 2.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.9 | 9.6 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.9 | 4.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.9 | 0.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.9 | 3.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.9 | 6.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.9 | 12.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.9 | 2.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.9 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.8 | 2.5 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.8 | 3.4 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.8 | 5.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.8 | 5.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.8 | 7.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.8 | 3.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.8 | 2.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.8 | 4.2 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 0.8 | 3.3 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.8 | 2.5 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.8 | 3.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.8 | 4.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.8 | 3.2 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.8 | 6.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 | 3.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.8 | 4.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.8 | 2.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.8 | 3.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.8 | 2.4 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.8 | 2.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.8 | 4.0 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.8 | 2.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.8 | 0.8 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.8 | 4.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.8 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 | 3.2 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.8 | 2.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.8 | 10.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.8 | 3.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 | 2.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.8 | 1.6 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.8 | 3.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.8 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.8 | 1.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.8 | 5.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.8 | 2.3 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.8 | 3.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.8 | 3.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.8 | 2.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 1.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.8 | 3.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.8 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.8 | 0.8 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.8 | 5.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.8 | 2.3 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.8 | 0.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.8 | 7.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 | 5.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.7 | 27.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 | 2.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.7 | 2.2 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.7 | 2.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.7 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.7 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.7 | 0.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.7 | 2.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.7 | 1.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.7 | 0.7 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.7 | 0.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.7 | 2.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.7 | 0.7 | GO:0031929 | TOR signaling(GO:0031929) |
| 0.7 | 2.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.7 | 5.1 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.7 | 11.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.7 | 2.9 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
| 0.7 | 2.9 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.7 | 2.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.7 | 2.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.7 | 0.7 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.7 | 3.6 | GO:0000050 | urea cycle(GO:0000050) |
| 0.7 | 4.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.7 | 0.7 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 0.7 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.7 | 3.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 | 0.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.7 | 6.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.7 | 0.7 | GO:0060022 | hard palate development(GO:0060022) |
| 0.7 | 9.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 2.1 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.7 | 2.1 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.7 | 4.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.7 | 2.1 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.7 | 4.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 | 2.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.7 | 2.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.7 | 3.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.7 | 2.0 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.7 | 2.7 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.7 | 4.7 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.7 | 6.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 8.7 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.7 | 8.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.7 | 2.7 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.7 | 0.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.7 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 1.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.7 | 2.6 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.7 | 2.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.7 | 9.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 3.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.7 | 2.0 | GO:2000340 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.7 | 5.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.7 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 2.0 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 | 2.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.7 | 4.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.6 | 2.6 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 | 1.3 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
| 0.6 | 6.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.6 | 2.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.6 | 2.6 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.6 | 3.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.6 | 5.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 | 8.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.6 | 5.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 5.1 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.6 | 0.6 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.6 | 1.9 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 | 3.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 1.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.6 | 4.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 3.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.6 | 3.1 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.6 | 3.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 | 2.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.6 | 10.4 | GO:0015871 | choline transport(GO:0015871) |
| 0.6 | 1.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.6 | 2.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.6 | 1.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.6 | 0.6 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.6 | 1.8 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.6 | 4.8 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.6 | 0.6 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.6 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 | 1.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.6 | 2.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.6 | 6.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.6 | 0.6 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.6 | 3.0 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.6 | 3.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.6 | 5.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.6 | 1.8 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.6 | 4.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.6 | 1.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.6 | 1.8 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.6 | 2.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.6 | 1.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.6 | 3.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.6 | 1.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.6 | 2.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.6 | 1.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.6 | 5.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.6 | 1.8 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 0.6 | 7.0 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.6 | 4.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.6 | 2.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.6 | 2.3 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.6 | 3.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.6 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.6 | 2.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 | 2.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.6 | 4.6 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.6 | 1.2 | GO:0060594 | mammary gland specification(GO:0060594) |
| 0.6 | 1.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.6 | 4.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 2.9 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.6 | 1.7 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.6 | 0.6 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.6 | 2.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.6 | 0.6 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.6 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.6 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.6 | 2.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.6 | 0.6 | GO:0090132 | epithelium migration(GO:0090132) |
| 0.6 | 3.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 | 2.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.6 | 3.3 | GO:0010814 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.6 | 2.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.6 | 0.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.6 | 3.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.6 | 3.3 | GO:0030047 | actin modification(GO:0030047) |
| 0.6 | 14.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.5 | 2.2 | GO:0097435 | fibril organization(GO:0097435) |
| 0.5 | 11.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.5 | 1.6 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 1.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 | 4.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.5 | 2.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 | 5.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 1.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.5 | 7.0 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 | 16.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 | 1.1 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 2.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.5 | 3.8 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.5 | 2.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.5 | 1.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 1.1 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.5 | 2.1 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.5 | 1.1 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.5 | 1.6 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.5 | 3.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.5 | 2.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 | 5.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.5 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.5 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.5 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 | 5.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 | 0.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.5 | 4.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 5.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 | 13.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 | 3.6 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.5 | 1.5 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.5 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.5 | 2.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 1.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 4.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.5 | 6.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 1.5 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 | 3.5 | GO:0015791 | polyol transport(GO:0015791) myo-inositol transport(GO:0015798) |
| 0.5 | 5.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.5 | 5.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 | 3.0 | GO:0042335 | cuticle development(GO:0042335) |
| 0.5 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.5 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.5 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.5 | 3.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 2.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.5 | 1.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.5 | 0.5 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.5 | 2.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 | 2.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 | 3.0 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.5 | 3.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 | 1.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.5 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.5 | 1.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.5 | 2.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.5 | 1.0 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.5 | 1.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.5 | 3.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.5 | 9.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.5 | 1.0 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.5 | 1.0 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.5 | 2.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.5 | 5.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.5 | 1.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.5 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 | 6.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 1.5 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 | 1.0 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.5 | 1.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.5 | 10.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.5 | 0.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 | 1.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 | 1.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.5 | 2.4 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
| 0.5 | 4.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.5 | 6.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.5 | 2.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.5 | 23.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.5 | 3.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.5 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 1.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.5 | 1.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.5 | 3.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 2.4 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.5 | 1.9 | GO:1902304 | phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
| 0.5 | 1.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.5 | 1.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 | 3.8 | GO:0030578 | PML body organization(GO:0030578) |
| 0.5 | 0.9 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.5 | 1.4 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.5 | 2.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 1.9 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.5 | 2.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.5 | 3.7 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.5 | 2.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.5 | 2.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 1.9 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.5 | 2.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.5 | 2.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.5 | 2.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.5 | 1.4 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.5 | 2.8 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.5 | 0.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 | 3.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.5 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.5 | 1.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.5 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 2.3 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
| 0.5 | 4.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.5 | 2.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.5 | 11.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.5 | 1.8 | GO:0045401 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) beta selection(GO:0043366) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 0.5 | 2.3 | GO:0032796 | uropod organization(GO:0032796) |
| 0.5 | 2.8 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.5 | 2.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 | 1.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.5 | 0.9 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.5 | 2.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 7.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.5 | 5.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.5 | 5.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.5 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 2.3 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.5 | 0.5 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.5 | 3.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.5 | 1.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.5 | 9.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.4 | 3.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.4 | 0.4 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 | 3.6 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.4 | 4.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.4 | 1.3 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 1.3 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 0.4 | 1.3 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.4 | 2.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 | 1.8 | GO:0048378 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.4 | 2.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 0.4 | 8.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.4 | 1.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.4 | 3.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 2.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 | 1.3 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.4 | 4.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 | 5.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 | 1.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.4 | 11.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 | 0.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 | 0.9 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
| 0.4 | 0.4 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
| 0.4 | 7.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 2.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 | 1.3 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.4 | 1.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.4 | 0.9 | GO:1900390 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.4 | 1.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 3.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.4 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.4 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 3.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 | 1.3 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.4 | 3.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.4 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 | 6.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 | 0.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.4 | 1.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.4 | 0.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.4 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.4 | 0.4 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.4 | 2.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 | 3.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.4 | 3.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.4 | 1.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.4 | 1.3 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.4 | 1.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.4 | 1.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.4 | 3.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.4 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
| 0.4 | 3.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 | 2.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 0.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 | 7.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.4 | 7.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 4.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.4 | 1.2 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.4 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.4 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.4 | 2.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 4.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.4 | 2.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.4 | 2.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.4 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.4 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 2.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.4 | 7.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.4 | 3.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 2.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 1.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.4 | 0.4 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.4 | 3.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.4 | 3.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 0.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.4 | 2.0 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 | 1.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.4 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.4 | 2.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.4 | 5.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.4 | 4.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 12.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.4 | 2.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 | 8.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.4 | 2.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 0.4 | 5.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 | 4.0 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.4 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.4 | 1.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 | 2.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.4 | 2.4 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 0.8 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.4 | 2.8 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.4 | 2.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 2.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.4 | 3.9 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.4 | 3.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.4 | 1.2 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 0.4 | 3.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.4 | 2.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.4 | 1.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.4 | 1.2 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.4 | 3.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 0.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 | 3.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 2.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 | 6.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.4 | 3.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.4 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 1.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 1.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.4 | 1.2 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.4 | 7.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.4 | 1.5 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
| 0.4 | 0.8 | GO:0048597 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 | 0.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.4 | 3.8 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.4 | 2.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.4 | 5.0 |